[go: up one dir, main page]

HK1262170A1 - Treatment of retinal degeneration using progenitor cells - Google Patents

Treatment of retinal degeneration using progenitor cells Download PDF

Info

Publication number
HK1262170A1
HK1262170A1 HK19122086.2A HK19122086A HK1262170A1 HK 1262170 A1 HK1262170 A1 HK 1262170A1 HK 19122086 A HK19122086 A HK 19122086A HK 1262170 A1 HK1262170 A1 HK 1262170A1
Authority
HK
Hong Kong
Prior art keywords
treatment
progenitor cells
retinal degeneration
retinal
degeneration
Prior art date
Application number
HK19122086.2A
Other languages
Chinese (zh)
Inventor
Harris Ian
Cao Jing
Sophia DEJNEKA Nadine
Original Assignee
Janssen Biotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech, Inc. filed Critical Janssen Biotech, Inc.
Publication of HK1262170A1 publication Critical patent/HK1262170A1/en

Links

HK19122086.2A 2015-12-04 2016-12-01 Treatment of retinal degeneration using progenitor cells HK1262170A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/263,463 2015-12-04

Publications (1)

Publication Number Publication Date
HK1262170A1 true HK1262170A1 (en) 2020-01-10

Family

ID=

Similar Documents

Publication Publication Date Title
CA3244408A1 (en) Therapeutic compositions, combinations, and methods of use
EP3268465A4 (en) Methods of cancer treatment using activated t cells
EP3256113A4 (en) Treatment of hypoparathyroidism
EP3145875A4 (en) Electrochemical treatment methods
EP3233096A4 (en) Treatment of retinal degeneration using progenitor cells
EP3240612A4 (en) Methods of treating retinal diseases
EP3191100A4 (en) Cenicriviroc combination therapy for the treatment of fibrosis
GB201403260D0 (en) Treatment of retinal degeneration using gene therapy
EP3119401A4 (en) Cenicriviroc for the treatment of fibrosis
EP3139935A4 (en) Therapeutic placental compositions, methods of making and methods of use
EP3189135A4 (en) Retinal ganglion cells and progenitors thereof
EP3157504A4 (en) Stem cell stimulating compositions and methods
EP3113771A4 (en) Therapeutic uses of ibogaine and related compounds
EP3518943A4 (en) Methods of adoptive cell therapy
EP3213762A4 (en) Novel treatment of cornea using laminin
EP3145543A4 (en) Treatment of eosinophil or mast cell related disorders
EP3297619A4 (en) Therapeutic uses of l-4-chlorokynurenine
EP3233174A4 (en) Intraocular delivery of bioactive molecules using iontophoresis
EP3213761A4 (en) Novel treatment of retina and nerve using laminin
EP3148556A4 (en) Skin treatment formulations
ZA201704521B (en) Treatment of ocular conditions using progenitor cells
EP3209131A4 (en) Compositions and methods for treatment with hemopexin
EP3151862A4 (en) Therapeutic detoxification compositions and methods of making and using same
EP3384009A4 (en) Treatment of retinal degeneration using progenitor cells
EP3242662A4 (en) Treatment of filarial diseases